Jane Street’s NexImmune, Inc. Common Stock NEXI Stock Holding History

Jane Street’s Portfolio NEXI Stock Details NEXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,799	Closed	-$12.7K	–	9587
2023 Q2	$12.7K	Buy	+1,799	New	+$15.5K	﹤0.01%	8408
2021 Q2	–	Sell	-529	Closed	-$252K	–	10580
2021 Q1	$252K	Buy	+529	New	+$288K	﹤0.01%	7941

Other funds holding NEXI

SPC

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Allen Operations New York $670M AUM 26.43% 1-Year Est. Return

ECG

EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

MCM

M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return

Caprock Group Boise, Idaho $5.22B AUM 42.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jane Street's NEXI Position: Q3 2023 in Review

Jane Street sold out of NexImmune, Inc. Common Stock (NEXI) in Q3 2023, closing a stake of 1,799 shares — an estimated $12.7K sold.

Jane Street first reported a position in NEXI in Q1 2021 and held it in 2 quarters. The position peaked at $252K in Q1 2021. 30 funds tracked by Wall St. Rank hold NEXI as of Q3 2023.

Jane Street reported no remaining NexImmune, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Jane Street sold 1,799 NexImmune, Inc. Common Stock shares in Q3 2023, an estimated $12.7K.
Jane Street first reported a position in NexImmune, Inc. Common Stock in Q1 2021 and held it in 2 quarters.
Jane Street's NexImmune, Inc. Common Stock position peaked at $252K in Q1 2021.
30 funds tracked by Wall St. Rank held NexImmune, Inc. Common Stock as of Q3 2023.

Based on Jane Street's 13F filing for Q3 2023, filed 15 Nov 2023.